SC 13D

Company

Arcus Biosciences, Inc.

Filed

March 5, 2020

Accession Number

0001564590-20-008994

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →